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ABSTRACT
Introduction: Patients with acute respiratory problems
poses a diagnostic challenge because similar
symptoms can be caused by various pathological
conditions. Focused ultrasound examination (f-US) of
the heart and lungs has proven to increase the
diagnostic accuracy in these patients. In this protocol
of a randomised multicentre trial, we study the effect
of f-US of the heart and lungs in patients with
respiratory problems performed by emergency
physicians (EP) as soon as the patient arrives to the
emergency department (ED). The primary outcome is
the number of patients with a correct presumptive
diagnosis at 4 hours from admission.
Methods and analysis: This is a semiblinded
randomised prospective study. 288 patients will be
included and randomised into the control or
intervention group. All patients receive a standard
diagnostic evaluation by the EP to assess the primary
presumptive diagnosis. Investigators are EP, with
varying degrees of experience in f-US, who perform an
f-US of the heart and lungs in patients in both
treatment arms. f-US results in the intervention group
are non-blinded to the treating EP to be included in the
assessment of the 4-hour presumptive diagnosis. As
standard for correct diagnosis, we perform a blinded
journal audit after discharge. As primary analysis, we
use the intention-to-treat analysis.
Conclusions: This study is the first multicentre trial in
EDs to investigate whether f-US, in the hands of the
EP, increases the proportion of correct diagnosis at
4 hours after arrival when performed on patients with
respiratory problems.
Ethics and dissemination: This trial is conducted in
accordance with the Helsinki II Declaration and
approved by the Danish Data Protection Agency and
the Committee on Biomedical Research Ethics for the
Region of Southern Denmark. Results will be
published in accordance with the CONSORT statement
in a peer-reviewed scientific journal regardless of the
outcome.
Trial registration number: NCT02550184; Pre-results.
INTRODUCTION
Patients arriving to the emergency department
(ED) with symptoms of acute respiratory pro-
blems are often a diagnostic challenge.
Despite similar clinical symptoms, the aeti-
ology can vary and require different treatments
and interventions.1 Earlier studies have found
that at least one diagnosis was missed in >20%
of these patients and that >30% of them
received a suboptimal treatment leading to
increased length of stay at hospital and
increased mortality.1–3 The assessment of a fast
and correct diagnosis is therefore of high
importance in these patients where instant
treatment may be lifesaving.1 2 4–6
Focused ultrasound examination (f-US) of
the lungs and heart has, over the past years,
emerged as a fast, non-invasive, bedside tool
for diagnosing diseases in the chest. This has
led to the development of evidence-based
guidelines describing indications, technical
performance and interpretation of ultra-
sound of the lungs and heart,7–9 as well as
guidelines for the implementation of f-US on
patients in the EDs and intensive care
units.10–13
Alongside standard paraclinical (eg, blood
samples, ECG, chest X-ray) and physical
examination, several trials have investigated
the impact of an f-US on the diagnostic
accuracy of some of the most common dis-
eases encountered in patients with symptoms
of respiratory problems in the EDs (eg, pneu-
monia, chronic obstructive lung disease, pul-
monary oedema, lung embolism, acute heart
failure).2 3 14–29 Most of these studies proved
a high diagnostic accuracy when using an
f-US alongside standard diagnostic testing
compared to standard diagnostic testing
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alone. Some even found that the diagnostic accuracy of
certain pulmonary diseases was superior when it was
assessed using f-US compared to a chest X-ray examin-
ation.18 One single centre study found a signiﬁcant
increase in diagnostic accuracy as well as in correctly pre-
scribed treatment at 4 hours after the patient’s arrival to
the ED. This was made by adding an f-US of the heart,
lungs and deep veins to standard clinical testing of
patients with respiratory problems.3
Unfortunately, the results from these studies are not
directly transferable to daily clinical practice as most of
them are designed as single centre studies and some
even performed by single investigators highly skilled in
f-US.2 3 14 16 18–20 22
In this study, we aim to investigate whether adding an
f-US of the lungs and heart to the standard diagnostic
examination in patients with signs and symptoms of
respiratory problems increases the proportion of patients
with a correct diagnosis established at 4 hours after
admittance. The study will be performed as a rando-
mised pragmatic multicentre trial. The f-US will be per-
formed by emergency physicians (EP) who attend to
patients in the ED on a regular basis.
METHODS
Design
The trial is designed as a prospective randomised semi-
blinded, multicentre study with a parallel group design,
an allocation ratio of 1:1 and as a superiority study. The
protocol has been developed from the single centre
study performed by one expert-investigator.3 As far as
possible, we mimic the study design and transfer it into
a multicentre design as well as comply with the few
points of criticism the study has received.30
Study flow and patient enrolment
Patient enrolment started in October 2015 and is esti-
mated to be ﬁnished in December 2016. We aim to
include 288 patients admitted to nine different EDs.
Enrolment will be performed in a non-consecutive
manner by local investigators from each ED
(ﬁgure 1). Patients comprise of those who are acutely
admitted to the ED with symptoms of respiratory
problems as their primary symptom. The investigator
will screen the patients for inclusion according to the
inclusion and exclusion criteria shortly after their
arrival (box 1).
Figure 1 Enrolment and patient flow in the study.
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Given that all inclusion criteria and none of the exclu-
sion criteria are fulﬁlled, the investigator will provide
the patient with oral and written information (see
online supplementary appendix I) about the study in
order to achieve informed consent whereafter he can
draw a randomisation number in the assigned database.
A primary presumptive diagnosis upon the patient’s
arrival will be assessed by the EP for patients in both
groups using the standard method of diagnostic assess-
ment (eg, clinical assessment, blood samples, ECG,
chest X-ray). Without knowledge of the primary pre-
sumptive diagnosis, the investigator performs an f-US of
the heart and lungs on patients in the intervention and
control group and gathers information on the basic
clinical values upon the patient’s arrival.
The f-US results from patients in the control group
remain blinded for the treating physician. But for
patients in the intervention group, the f-US results will
be non-blinded to the treating physician once he has
declared his primary presumptive diagnosis to the inves-
tigator. Non-blinding of f-US results will be performed
by the investigator in oral and in writing, on a paper
record, marked with the patient’s personal ID number
and stored in an accessible briefcase in the ED. Once
the f-US results are non-blinded to the EP, he can
re-evaluate his primary presumptive diagnosis and
treatment.
Further diagnostic evaluation and treatment will
proceed in accordance with the ED’s clinical guidelines.
To ensure that we reach target sample size by an
adequate patient enrolment, we have taken the following
precautions: a pilot study was performed in the ED in
one of the smallest hospitals participating in this trial
and showed that an average of four eligible patients per
day on an 8-hour shift in daytime. The investigators
work between 1 and 4 days per week in the ED and they
agreed on an inclusion rate of 20–25 patients per investi-
gator. This gives an estimate of 12–15 investigators neces-
sary to include 288 patients and an estimate of inclusion
time of 1–4 weeks. To this we added the risk of investiga-
tors pausing inclusion due to busy shifts, holiday, sick
leave or maternity leave or even dropping out of the
project prior to completing their inclusion rates.
We here ended with a need for 20 investigators and an
inclusion time of 15 months, including 3 months, for a
local initiation of inclusion in the participating centres.
Recruitment of investigators
Investigators are found via MR’s network of ultrasound
enthusiasts and by oral presentations of the study on
conferences and meetings among physicians and
researchers of emergency medicine in Denmark. Once a
potential investigator proved interest in participating in
the study, MR supplied him or her with documents
about the expected tasks as investigator, a description of
the protocol, agreements on afﬁliation on the ﬁnal
product and a questionnaire regarding: their level of
education, their attachment to the ED, their ultrasound
skills, a description of the type of ultrasound equipment
in the ED and the availability of this.
If the investigator fulﬁlled the basic requirements and
still wished to become an investigator, MR contacted the
management of the ED, by email, to ask for permission
to initiate the trial in their department. Attached to this
request was the study protocol along with the expected
tasks of the investigator and the agreements on afﬁli-
ation of the ﬁnal product. Once the authorisation from
the department leaders was attained, we agreed on a
date for the educational programme, regarding the data-
base and the ultrasound protocol. This programme was
set to take place in the investigators’ own environment.
Until then, the investigators were provided with regular
updates on study progress and with e-learn material
about the ultrasound protocol.
Standards and diagnoses
As standard for the ﬁnal diagnoses, we will make a
blinded journal audit using the results from the f-US as
well as predeﬁned diagnostic criteria (see online
supplementary appendix II). The audit will be under-
taken once the patient has left the hospital. It will be
performed by two physicians who, in case of discrepancy,
will be complemented by a third auditor who will set the
ﬁnal decision.
As standard for a correct interpretation of the f-US,
specialists in ultrasound of the lungs and the heart will
perform a blinded audit using predeﬁned diagnostic cri-
teria (see online supplementary appendix III). The spe-
cialists will be blinded with respect to the investigator’s
evaluation of the f-US. All f-US recordings are saved as
raw data.
The primary presumptive diagnosis is assessed by the
EP who writes it on a predesigned paper record and
Box 1 Inclusion and exclusion criteria for enrolment
Inclusion criteria.
All four criteria have to be fulfilled.
1. The patient is 18 years or more.
2. The patient has arrived acutely to the emergency department
(ED).
3. The patient presents with one or more of the following signs
and symptoms as the primary symptom:
▸ Cough.
▸ Dyspnoea.
▸ Chest pain.
▸ Respiration frequency >20/min.
▸ Peripheral oxygen saturation <95%.
4. Written informed consent from habile patient.
Exclusion criteria.
1. The patient is not capable of giving informed consent.
2. The focused ultrasound examination (f-US) of the lungs or the
heart has already been performed by others than the investiga-
tor in relation to the primary assessment.
3. The randomisation and f-US cannot be performed within
4 hours from the patient′s admittance to the ED.
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hands it to the investigator prior to non-blinding of the
f-US results. Subsequently, the investigator adds the
primary presumptive diagnosis to the database.
The 4-hour presumptive diagnosis will be found by a
blinded medical journal audit once the patient has left
the hospital. For this, we use the last performed evalu-
ation registered in the patient’s medical record within
4 hours from admission to the ED. The speciﬁc cut-off
at 4 hours is chosen because several EDs throughout
Denmark have a 4-hour time limit when primary results
(eg, blood sample, ECG, X-ray) and a presumptive diag-
nosis with relevant treatment should be started.
Study sites
The study sites comprise nine Danish EDs, hereof three
EDs of tertiary referral hospitals. All participating EDs
have admissions to the medical unit and represent a
broad variation of the different constellations of EDs in
Denmark concerning the number of admissions per
year, opening hours as well as visitation of patients.
Patients suspected of having a heart disease (eg, acute
myocardial infarction or arrhythmia) are either admitted
to the ED or directly to the cardiology department. Both
constellations are represented in this study. There is no
upper limit to the number of inclusions per ED. There
are one to ﬁve investigators per ED and each investigator
is expected to include 20–25 patients. List of study sites
can be obtained from the corresponding author.
Randomisation
Randomisation is performed using an online block ran-
domisation database (REDCap OPEN) in which per-
muted blocks of random numbers have been listed to
ensure an equal number of patients in both study arms
at each centre.31 The allocation sequence of randomisa-
tion numbers is generated by the data manager from
REDCap OPEN and the project manager, MR, using an
online random number service.32 The randomisation
numbers are then transferred into the REDCap OPEN
database assigned to this study. The investigator registers
each patient in the database whereby he receives the
patient’s unique identiﬁcation number and randomisa-
tion number which allocates the patient to either inter-
vention or control group.
Investigators and educational programme
The local investigators are medical doctors who are
either specialists or in specialist training and who receive
patients in the ED on a regular basis. All the investiga-
tors use f-US in daily practice but have varying degrees
of experience with f-US.
The project manager is responsible for educating the
investigators in the data collection and the f-US proto-
col. This is undertaken as an e-learning presentation
with instructional videos followed by a 4-hour onsite oral
presentation of the project and the collection and regis-
tration of data as well as an individual evaluation of each
investigator’s f-US skills (eg, by hands on).33 All
investigators must pass a multiple choice questionnaire
test and be able to perform the f-US protocol prior to
initiation of inclusion (see online supplementary
appendix IV). During the period of inclusion, investiga-
tors can take daily contact to the project manager with
any question. Further supervision will take place if
necessary.
The ultrasound protocol
To reduce the time spent on f-US, but still keep the
focus on the speciﬁc signs of pathology of the heart and
lungs, which we look for in the acute situation, we have
modiﬁed the ultrasound protocols as follows.
The f-US of the lungs is a modiﬁcation of the ultra-
sound protocol used by Laursen et al.3 It is originally
modiﬁed from the principles of lung ultrasound by
Volpicelli et al28 and Lichtenstein,34 and is performed as
follows: the anterior and lateral part of thorax is divided
into a superior and inferior quadrant. Each quadrant
represents a zone in which the probe shall be placed
centrally and create a transverse picture of the costae
and pleura. A sequence of at minimum 4 s, including at
least one inspiration and one expiration, shall be
recorded in all zones.
The focused cardiac ultrasound is performed accord-
ing to the principles described in the international
evidence-based guideline.9 The views used are the four-
chamber picture of the heart achieved either from a
subxiphoid or an apical window. A sequence of
minimum 6 s of the heart shall be recorded.
Blinding
To ensure a proper blinded audit of the medical record,
we have instructed investigators and treating EP to leave
all information regarding the patient’s unique identiﬁca-
tion number, randomisation number and f-US ﬁndings
out of the medical record.
All f-US results from both groups are registered in the
REDCap OPEN database only accessible for investigators
and project managers.31 Only non-blinded f-US results
are stored in an accessible briefcase in the ED for the
EP to use.
Outcomes
Primary outcome
To investigate whether adding an f-US of the lungs and
heart to the standard diagnostic examination in patients
with signs and symptoms of respiratory problems
increases the proportion of patients with a correct diag-
nosis established at 4 hours after admittance when f-US
is performed by the local EP. The study will be per-
formed as a randomised pragmatic multicentre trial.
Secondary outcomes
For the control and intervention group, we want to
examine:
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1. The sensitivity, speciﬁcity, positive and negative pre-
dictive values and diagnostic accuracy of the primary
presumptive diagnoses made upon arrival.
2. The proportion of patients receiving a correct
primary presumptive diagnosis made upon arrival.
3. The proportion of f-US with a correct diagnostic
assessment.
4. The proportion of patients who within 4 hours after
admission to the ED is given the correct treatment.
5. Time spent in the ED (hours).
6. Time spent at hospital (days).
7. The proportion of patients being discharged from
the ED and directly to their home.
8. The proportion of patients being discharged from
the ED to a hospital ward.
9. The proportion of patients being discharged from
the ED to the intensive care unit.
10. The proportion of patients being readmitted to hos-
pital within 30 days from discharge.
11. In-hospital mortality.
12. 30-Day mortality.
Sample size
The sample size estimate of this study is based on the
results from the study by Laursen et al.3 We expect that
∼65% of the patients in the control group will have a
correct presumptive diagnosis at 4 hours after admission
to the ED. A clinically relevant absolute improvement of
the tentative diagnosis using f-US in a multicentre study
is set to be 15%. To detect a 15% increase in the
number of correct tentative diagnoses, from 65% in the
control group to 80% in the intervention group, with an
80% chance for detection and a level of signiﬁcance of
5%, 272 included patients are needed. The estimated
drop out is 6% and increases the number of inclusion to
288 patients. This gives 144 patients in each group
(intervention/control group). Sample size calculations
were made using the online database for clinical trials,
Sealed Envelope.32
Data analysis
An intention-to-treat analysis will be performed on all
participants and will serve as the primary analysis for all
objectives in this study. In order to demonstrate a suc-
cessful randomisation and the presence of even baseline
groups, we register descriptive statistics (age, sex,
smoking status, medical history, medication, triage
colour) as well as clinical values and patient’s primary
symptom on admission at the ED. Data will be speciﬁed
as follows: categorical data by number and proportion of
patients. Continuous data by number of patients (n),
mean, SD, median, minimum and maximum. Missing
data will be handled by the use of the statistical method
multiple imputation.
Data analysis of primary end point
To determine whether there is a difference in the pro-
portion of patients with a correct/incorrect presumptive
diagnosis between the intervention group and the
control group, we will use a χ2 test or the Fischer exact
test.
Data analysis of secondary end points
To compare the intervention group with the control
group, we will use the following tests: for the comparison
of means, the Student’s t-test; for the comparison of
medians, the Mann-Whitney test; and for the compari-
son of proportions, the χ2 or the Fisher exact test. A two-
sided signiﬁcance level of 5% will be applied to all tests.
To assess the diagnostic accuracy of the primary pre-
sumptive diagnosis, the 4-hour presumptive diagnosis
and the f-US, we will calculate the sensitivity, speciﬁcity,
positive and negative predictive values and the diagnos-
tic accuracy with 95% CI based at a binominal distribu-
tion. To assess the interobserver agreement on the f-US
results between investigators and the ultrasound specia-
lists, we use the Cohen’s κ coefﬁcient. Data analysis will
be conducted using STATA Release V.14.0 (Stata Corp)
including professional statistical advice.
Data management
Data speciﬁed in the study protocol will be directly docu-
mented and securely stored in the password protected
database assigned for this study in REDCap OPEN, SDU.
REDCap is a secure web application designed to support
data capture for research at which the University of
Southern Denmark has its own secure database access.35
The project manager is responsible for the database
construction in cooperation with a data manager from
OPEN (SDU) as well as for data acquisition, storage,
monitoring ﬂow and validation.
In this database, each patient receives a unique identi-
ﬁcation number securing patient identity. The investiga-
tors will only gain access to this database to withdraw a
randomisation number and to enter data regarding the
inclusion/exclusion, basic values upon arrival, f-US ﬁnd-
ings and the primary presumptive diagnoses.
Additional clinical data will be available from the elec-
tronic patient records in which there is no information
on the randomisation number or f-US ﬁndings. Basic
characteristics will be entered into the database by the
project manager. Data regarding the blinded audit of
the medical records will be entered into the database by
the auditors who have no access to other data entry
forms than those regarding the blinded audit. A data
monitoring committee was not used. All the data
reported are linked to each speciﬁc investigator and
data reporting are monitored by project manager, MR,
on a weekly basis.
F-US ﬁndings will be stored on secured external hard
drives where patients will be entered by their unique
identiﬁcation number to secure patient identity and to
enable a blinded audit by the specialists in f-US. Only
the patient’s informed consent for participation and
non-blinded f-US ﬁndings are on paper format. No
interim analysis or end point adjustments are planned.
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The ﬁnal decision to end this trial before sample size is
attained will be made by agreement between the project
manager, MR, and her supervisors.
ETHICS AND DISSEMINATION
The f-US is a method of investigation which has no known
adverse effects. It will be performed in accordance with
the local hospital guidelines. To avoid deprivation of a
diagnostic tool in the control group, we have taken the fol-
lowing precaution for all included patients because f-US is
gaining ground in few of the participating EDs and
because the f-US ﬁndings are blinded in the control
group: in case any f-US rises suspicion of a life-threatening
condition, the f-US ﬁndings will immediately be non-
blinded to the EP in charge of the patient (box 2).
The study will be conducted in accordance with the
Helsinki II Declaration,36 and as approved by the Danish
Data Protection Agency (identiﬁcation number 13/
12076),37 and the Committee on Biomedical Research
Ethics for the Region of Southern Denmark (identiﬁca-
tion number S-20150090) with a dispensation from the
normal rules for time for consideration since the f-US
must be performed shortly after the patient has arrived
to the ED. All data are stored and managed according
to the laws and regulations of the Danish Data
Protection Agency. The study is registered with Clinical
trials (NCT02550184).
In the event that signiﬁcant modiﬁcations to the
protocol become necessary, MR will inform the coau-
thors, trial registers and investigators by mail and in
person to ensure their implementation.
The results of this study will be published according to
the CONSORT statement in peer-reviewed scientiﬁc
journals regardless of the outcome.38
STRENGTHS AND LIMITATIONS
The generalisability of this study is supported by the multi-
centre design with investigators comprised of local EP
from many specialties. The investigators represent the
general level of expertise in f-US nationwide. The sample
size is powered to detect a clinically signiﬁcant improve-
ment in the proportion of patients with a correct diagnosis
and the blinded journal audit is strengthened by inclusion
of f-US ﬁndings in the assessment of the ﬁnal diagnosis.
The study has limitations: the investigators are
recruited via MR’s network of ultrasound enthusiasts.
These doctors work in Danish EDs and they use ultra-
sound as part of their daily diagnostic procedures, but
they cannot represent all doctors in the EDs.
Furthermore, there is a risk of selection bias since
patients are not consecutively enrolled. There is also a
risk of non-blinding of f-US results before the primary
or the 4-hour presumptive diagnosis has been attained
since the investigators often hold the treatment responsi-
bility. The study is not powered to investigate for differ-
ences in morbidity and mortality.
CONCLUSION
To our knowledge, this study is the ﬁrst multicentre trial
in the EDs to investigate whether an f-US in the hands
of the EP can increase the proportion of patients with a
correct diagnosis as well as the proportion of correctly
initiated treatments on patients with signs of respiratory
problems at 4 hours after their arrival to the ED. This
trial holds the potential to develop evidence-based opti-
misation of early diagnostic accuracy in these patients.
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